Citigroup Lowers Bruker (NASDAQ:BRKR) Price Target to $80.00

Bruker (NASDAQ:BRKR – Free Report) had its price objective trimmed by Citigroup from $95.00 to $80.00 in a research report released on Wednesday, Benzinga reports. The firm currently has a buy rating on the medical research company’s stock. A number of other brokerages have also weighed in on BRKR. StockNews.com lowered Bruker from a buy […]

Leave a Reply

Your email address will not be published.

Previous post StockNews.com Begins Coverage on CalAmp (NASDAQ:CAMP)
Next post Susquehanna Raises ASML (NASDAQ:ASML) Price Target to $1,300.00